Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 clinical trial evaluating the efficacy and safety of biphasic insulin aspart 30 in combination with metformin fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Novolog Mix 30 (biphasic insulin aspart 30 (BIAsp 30))
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED